IT
Indapta Therapeutics Inc.
SEC filingOther Technology · Houston, TX
Amount raised$50.8Msold at filing
Total offering$51.6M$774K still open
Investors in the raise46count reported to the SEC
FiledOct 14, 2025first sale Sep 24, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Lori HuDirector
Fabio PucciDirector
Ronald MartellDirector
Mark FrohlichExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.